NCT06186401 2026-03-16Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T CellsUniversity of California, San FranciscoPhase 1 Recruiting20 enrolled
NCT06815029 2025-06-26Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant AstrocytomaCity of Hope Medical CenterPhase 1 Recruiting27 enrolled